801 related articles for article (PubMed ID: 10856437)
41. Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT).
Guo A; Marinaro W; Hu P; Sinko PJ
Drug Metab Dispos; 2002 Apr; 30(4):457-63. PubMed ID: 11901101
[TBL] [Abstract][Full Text] [Related]
42. MDR1 P-glycoprotein reduces influx of substrates without affecting membrane potential.
Luker GD; Flagg TP; Sha Q; Luker KE; Pica CM; Nichols CG; Piwnica-Worms D
J Biol Chem; 2001 Dec; 276(52):49053-60. PubMed ID: 11598111
[TBL] [Abstract][Full Text] [Related]
43. Differential effects of toremifene on doxorubicin, vinblastine and Tc-99m-sestamibi in P-glycoprotein-expressing breast and head and neck cancer cell lines.
Mubashar M; Harrington KJ; Chaudhary KS; Lalani el-N; Stamp GW; Peters AM
Acta Oncol; 2004; 43(5):443-52. PubMed ID: 15360048
[TBL] [Abstract][Full Text] [Related]
44. Imaging multidrug resistance P-glycoprotein transport function using microPET with technetium-94m-sestamibi.
Bigott HM; Prior JL; Piwnica-Worms DR; Welch MJ
Mol Imaging; 2005; 4(1):30-9. PubMed ID: 15967124
[TBL] [Abstract][Full Text] [Related]
45. Novel tetrahydroisoquinolin-ethyl-phenylamine based multidrug resistance inhibitors with broad-spectrum modulating properties.
Jekerle V; Klinkhammer W; Reilly RM; Piquette-Miller M; Wiese M
Cancer Chemother Pharmacol; 2007 Jan; 59(1):61-9. PubMed ID: 16636798
[TBL] [Abstract][Full Text] [Related]
46. Characterisation of the brain multidrug resistance protein (BMDP/ABCG2/BCRP) expressed at the blood-brain barrier.
Eisenblätter T; Hüwel S; Galla HJ
Brain Res; 2003 May; 971(2):221-31. PubMed ID: 12706238
[TBL] [Abstract][Full Text] [Related]
47. Visualization of multidrug resistance in vivo.
Hendrikse NH; Franssen EJ; van der Graaf WT; Vaalburg W; de Vries EG
Eur J Nucl Med; 1999 Mar; 26(3):283-93. PubMed ID: 10079321
[TBL] [Abstract][Full Text] [Related]
48. P-glycoprotein (MDR1/ABCB1) and breast cancer resistance protein (BCRP/ABCG2) restrict brain accumulation of the JAK1/2 inhibitor, CYT387.
Durmus S; Xu N; Sparidans RW; Wagenaar E; Beijnen JH; Schinkel AH
Pharmacol Res; 2013 Oct; 76():9-16. PubMed ID: 23827160
[TBL] [Abstract][Full Text] [Related]
49. In vitro transport of gimatecan (7-t-butoxyiminomethylcamptothecin) by breast cancer resistance protein, P-glycoprotein, and multidrug resistance protein 2.
Marchetti S; Oostendorp RL; Pluim D; van Eijndhoven M; van Tellingen O; Schinkel AH; Versace R; Beijnen JH; Mazzanti R; Schellens JH
Mol Cancer Ther; 2007 Dec; 6(12 Pt 1):3307-13. PubMed ID: 18089724
[TBL] [Abstract][Full Text] [Related]
50. Cationic lipophilic radiotracers for functional imaging of multidrug resistance.
Gomes CM
Curr Radiopharm; 2012 Apr; 5(2):113-23. PubMed ID: 22280111
[TBL] [Abstract][Full Text] [Related]
51. Multidrug resistance related molecules in human and murine lung.
Scheffer GL; Pijnenborg AC; Smit EF; Müller M; Postma DS; Timens W; van der Valk P; de Vries EG; Scheper RJ
J Clin Pathol; 2002 May; 55(5):332-9. PubMed ID: 11986335
[TBL] [Abstract][Full Text] [Related]
52. Study of monoglutathionyl conjugates TC-99M-sestamibi and TC-99M-tetrofosmin transport mediated by the multidrug resistance-associated protein isoform 1 in glioma cells.
Le Jeune N; Perek N; Denoyer D; Dubois F
Cancer Biother Radiopharm; 2005 Jun; 20(3):249-59. PubMed ID: 15989470
[TBL] [Abstract][Full Text] [Related]
53. Taxane-based reversal agents modulate drug resistance mediated by P-glycoprotein, multidrug resistance protein, and breast cancer resistance protein.
Brooks TA; Minderman H; O'Loughlin KL; Pera P; Ojima I; Baer MR; Bernacki RJ
Mol Cancer Ther; 2003 Nov; 2(11):1195-205. PubMed ID: 14617793
[TBL] [Abstract][Full Text] [Related]
54. Usefulness of technetium-99m tetrofosmin liver imaging to detect hepatocellular carcinoma and related to expression of P-glycoprotein or multidrug resistance associated protein-a preliminary report.
Ding HJ; Huang WT; Tsai CS; Chang CS; Kao A
Nucl Med Biol; 2003 Jul; 30(5):471-5. PubMed ID: 12831984
[TBL] [Abstract][Full Text] [Related]
55. Monitoring interactions at ATP-dependent drug efflux pumps.
Hendrikse NH
Curr Pharm Des; 2000 Nov; 6(16):1653-68. PubMed ID: 10974159
[TBL] [Abstract][Full Text] [Related]
56. Insights into the molecular mechanism of action of Celastraceae sesquiterpenes as specific, non-transported inhibitors of human P-glycoprotein.
Muñoz-Martínez F; Reyes CP; Pérez-Lomas AL; Jiménez IA; Gamarro F; Castanys S
Biochim Biophys Acta; 2006 Jan; 1758(1):98-110. PubMed ID: 16455045
[TBL] [Abstract][Full Text] [Related]
57. 5-Oxo-hexahydroquinoline derivatives as modulators of P-gp, MRP1 and BCRP transporters to overcome multidrug resistance in cancer cells.
Ranjbar S; Khonkarn R; Moreno A; Baubichon-Cortay H; Miri R; Khoshneviszadeh M; Saso L; Edraki N; Falson P; Firuzi O
Toxicol Appl Pharmacol; 2019 Jan; 362():136-149. PubMed ID: 30391378
[TBL] [Abstract][Full Text] [Related]
58. Flavonoids chrysin and benzoflavone, potent breast cancer resistance protein inhibitors, have no significant effect on topotecan pharmacokinetics in rats or mdr1a/1b (-/-) mice.
Zhang S; Wang X; Sagawa K; Morris ME
Drug Metab Dispos; 2005 Mar; 33(3):341-8. PubMed ID: 15608138
[TBL] [Abstract][Full Text] [Related]
59. Tariquidar and elacridar are dose-dependently transported by P-glycoprotein and Bcrp at the blood-brain barrier: a small-animal positron emission tomography and in vitro study.
Bankstahl JP; Bankstahl M; Römermann K; Wanek T; Stanek J; Windhorst AD; Fedrowitz M; Erker T; Müller M; Löscher W; Langer O; Kuntner C
Drug Metab Dispos; 2013 Apr; 41(4):754-62. PubMed ID: 23305710
[TBL] [Abstract][Full Text] [Related]
60. "Effect of the drug transporters ABCB1, ABCC2, and ABCG2 on the disposition and brain accumulation of the taxane analog BMS-275,183".
Marchetti S; Pluim D; Beijnen JH; Mazzanti R; van Tellingen O; Schellens JH
Invest New Drugs; 2014 Dec; 32(6):1083-95. PubMed ID: 25078948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
